Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present icad, inc. (NASDAQ: ICAD).

Full DD Report for ICAD

You must become a subscriber to view this report.


Recent News from (NASDAQ: ICAD)

iCAD announces AERB approval of Xoft System in India
iCAD ( ICAD +0.8% ) says that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® has received an Atomic Energy Regulatory Board (AERB) type approval for use in India. More news on: iCAD, Inc., Tech stocks news, Read more ...
Source: SeekingAlpha
Date: August, 29 2018 14:10
iCAD Announces AERB Approval of Xoft System in India
First installation of versatile, multi-platform Xoft System in India demonstrates strong, continued momentum in global commercialization of electronic brachytherapy (eBx) NASHUA, N.H. and HYDERABAD, India, Aug. 29, 2018 (GLOBE NEWSWIRE) --   iCAD, Inc . (NASDAQ: ICAD), a global m...
Source: GlobeNewswire
Date: August, 29 2018 08:00
Medical City Plano, a HCA Healthcare Facility, Adopts iCAD's Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer
Leading center becomes first in Texas to offer intraoperative radiation therapy with the advanced Xoft System to enhance patient care NASHUA, N.H. and PLANO, Texas, Aug. 28, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD), a global medical technology leader providing innova...
Source: GlobeNewswire
Date: August, 28 2018 08:00
Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer
SAN DIEGO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that it has appointed Andrew Sassine as Interim Chief Financial Officer (CFO), effective August 24, 2018. Mr. Sassine has served on Arcturus’ Board...
Source: GlobeNewswire
Date: August, 28 2018 07:00
iCAD's (ICAD) CEO Ken Ferry on Q2 2018 Results - Earnings Call Transcript
iCAD, Inc. (ICAD) Q2 2018 Earnings Conference Call August 14, 2018 4:30 PM ET Executives Jeremy Feffer – Investor Relations-LifeSci Advisors Ken Ferry – Chief Executive Officer Rich Christopher – Chief Financial Officer Analysts Per Ostlund – Cra...
Source: SeekingAlpha
Date: August, 14 2018 22:21

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-124.104.11544.124.02121,856
2018-12-113.984.104.2043.9364,616
2018-12-103.803.974.103.8022,766
2018-12-074.493.824.53313.67186,623
2018-12-064.004.074.123.90135,017

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1248,52790,83853.4215Short
2018-12-1112,91119,11467.5473Short
2018-12-103,9767,18355.3529Short
2018-12-0719,90846,84842.4949Short
2018-12-0628,88939,25273.5988Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ICAD.


About icad, inc. (NASDAQ: ICAD)

Logo for icad, inc. (NASDAQ: ICAD)

Not available

 

Contact Information

 

 

Current Management

  • Kenneth Ferry / CEO
  • W. Scott Parr / President, COO
  • Kevin Burns / CFO

Current Share Structure

  • Market Cap: $54,127,325 - 05/16/2018
  • Issue and Outstanding: 16,603,474 - 03/26/2018

 



Daily Technical Chart for (NASDAQ: ICAD)

Daily Technical Chart for (NASDAQ: ICAD)


Stay tuned for daily updates and more on (NASDAQ: ICAD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ICAD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ICAD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ICAD and does not buy, sell, or trade any shares of ICAD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/